Skip to main content

Table 1 Demographical data of 71 patients with mucinous carcinoma of the breast

From: Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma

Parameters(n=71)

Percentage

Age

mean 61.8 (26 – 95, median 64)

Tumor diameter (cm)

mean 3.1 (0.5 – 12.3, median 2.5)

Tumor location

39 (54.9%)/32 (45.1%)

     right/left

 

Subtype

23 (32.4%)/32 (45.1%)/16 (22.5%)

     MMBC/PMBC-A / PMBC-B

 

Pathological stage

23 (32.4%)/40 (56.3%)/8 (11.3%)

     I/II/III

 

pT

23 (32.4%)/38 (53.5%)/6 (8.5%)/ 4 (5.6%)

     T1/T2/T3/T4

 

pLymph node status

8 (11.3%)/63 (88.7%)

     Positive/Negative

 

Lymphovascular invasion

15 (21.1%)/56 (78.9%)

     Positive/Negative

 

Nuclear grade

55 (77.5%)/15 (21.1%)/1 (1.4%)

     1/2/3

 

EIC

31 (43.7%)/40 (56.3%)

     Positive/Negative

 

Hormone receptor status

68 (95.8%)/3 (4.2%)

     Positive/Negative

 

HER 2 status

1 (1.4%)/70 (98.6%)

     Positive/Negative

 

Ki67

8 (11.3%)/63 (88.7%)

     Positive/Negative

 

Recurrence

7 (9.9%)/64 (90.1%)

     Recurrence/no- Recurrence

 

Recurrence cases (n=7)

6 (85.7%)/0 (0.0%)/1 (14.3%)

     MMBC/PMBC-A/PMBC-B

 
  1. MMBC mixed mucinous carcinoma, PMBC pure mucinous carcinoma, EIC extensive intraductal component.